Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor

Bin Tu1, Yang He, Binfan Chen

  • 1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Rd, Shanghai 201203, China. yzhuang@simm.ac.cn.

Biomaterials Science
|November 10, 2020
PubMed

Insights

This study developed a novel deformable liposome system for delivering epigenetic drugs to remodel the tumor microenvironment in non-small cell lung cancer. The treatment effectively inhibited tumor growth by reprogramming macrophages and enhancing anti-tumor immunity.

Area of Science:

  • Oncology
  • Nanomedicine
  • Immunology

Background:

  • The tumor microenvironment (TME) and tumor-associated macrophages (TAM) are critical in non-small cell lung cancer (NSCLC) progression.
  • Epigenetic therapies offer potential for TME remodeling, but effective drug delivery remains a challenge.

Purpose of the Study:

  • To develop a deformable liposome (D-Lipo) system for codelivering vorinostat and simvastatin.
  • To investigate the efficacy of D-Lipo in a chemo-free therapeutic strategy for NSCLC by remodeling the TME.

Main Methods:

  • Formulation of deformable liposomes for dual drug delivery.
  • Evaluation of D-Lipo's intratumor infiltration and anti-tumor efficacy in xenografted lung tumors.
  • Analysis of immune cell populations (TAMs, CD8+ T cells, Tregs) and angiogenesis within the TME.

Main Results:

  • D-Lipo demonstrated enhanced intratumor infiltration and inhibited xenografted lung tumor growth.
  • The therapy successfully repolarized TAMs from M2 (pro-tumor) to M1 (anti-tumor) phenotype.
  • Significant reduction in pro-tumor M2 macrophages and regulatory T cells (Tregs), alongside an increase in anti-tumor M1 macrophages and CD8+ T cells, indicating TME remodeling and anti-angiogenesis.

Conclusions:

  • Deformable liposomes provide an effective platform for epigenetic drug codelivery, enabling chemo-free cancer therapy.
  • This strategy shows promise for remodeling the tumor microenvironment and enhancing anti-tumor immunity in solid tumors like NSCLC.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
103
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
97
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K